<p>加拿大市场表现出韧性，最近多伦多证券交易所（TSX）上涨超过 2%，尽管全球市场面临关税不确定性和经济压力。在这样的环境下，投资者往往会超越大型指数，寻找在小型股票等较不知名领域的机会。尽管 “便士股票” 这个术语可能显得过时，但这些较小或较新的公司在强大的财务支持和稳健的基本面下，仍然可以提供显著的增长潜力。</p>
<h3>加拿大十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Westbridge Renewable Energy (TSXV:WEB)</td>
<td>CA$0.61</td>
<td>CA$6170 万</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>NTG Clarity Networks (TSXV:NCI)</td>
<td>CA$1.69</td>
<td>CA$6998 万</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Orezone Gold (TSX:ORE)</td>
<td>CA$1.31</td>
<td>CA$68519 万</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Dynacor Group (TSX:DNG)</td>
<td>CA$4.70</td>
<td>CA$19839 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Amerigo Resources (TSX:ARG)</td>
<td>CA$1.69</td>
<td>CA$2.824 亿</td>
<td>✅ 2 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>PetroTal (TSX:TAL)</td>
<td>CA$0.57</td>
<td>CA$5.2169 亿</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>McCoy Global (TSX:MCB)</td>
<td>CA$2.66</td>
<td>CA$7094 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Findev (TSXV:FDI)</td>
<td>CA$0.48</td>
<td>CA$1318 万</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>BluMetric Environmental (TSXV:BLM)</td>
<td>CA$1.21</td>
<td>CA$4357 万</td>
<td>✅ 2 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Enterprise Group (TSX:E)</td>
<td>CA$1.26</td>
<td>CA$9846 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们 TSX 便士股票筛选器的 930 只股票的完整列表。</p>
<p>下面我们展示了一些经过筛选的股票。</p>
<h2>Calfrac Well Services (TSX:CFW)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Calfrac Well Services Ltd.及其子公司在加拿大、美国和阿根廷提供专业的油田服务，市值为 CA$2.9288 亿。</p>
<p><strong>运营：</strong> 该公司主要通过油井设备和服务产生收入，金额为 CA$15.7 亿。</p>
<p><strong>市值：</strong> CA$2.9288 亿</p>
<p>Calfrac Well Services 的市值为 CA$2.9288 亿，最近报告了 2024 年第四季度的净亏损，销售额下降。过去五年，该公司的债务显著减少，但其当前的净债务与股本比率仍高达 42.4%。虽然短期和长期负债由资产覆盖，但利息支付未能得到盈利的良好覆盖。最近的高管变动可能会影响未来的战略和运营。尽管去年盈利增长为负，Calfrac 预计在竞争激烈的能源服务行业中，未来的利润将适度增长 4.61%。</p>
<ul>
<li>点击这里了解 Calfrac Well Services 的细微差别，查看我们的详细财务健康报告。</li>
<li>查看我们的增长表现报告，以获取对 Calfrac Well Services 未来的洞察。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e9eb34c4-7b23-4bc4-a84f-cbb170d0732b/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e9eb34c4-7b23-4bc4-a84f-cbb170d0732b/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 4 月的 TSX:CFW 收入与支出细分</p>
<h2>Eupraxia Pharmaceuticals (TSX:EPRX)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Eupraxia Pharmaceuticals Inc.是一家临床阶段的生物技术公司，专注于发现、开发和营销生物技术领域的技术，市值为 CA$1.5917 亿。</p>
<p><strong>运营：</strong> Eupraxia Pharmaceuticals Inc.尚未报告任何具体的收入细分。</p>
<p><strong>市值：</strong> CA$1.5917 亿</p>
<p>Eupraxia Pharmaceuticals Inc.的市值为 CA$1.5917 亿，仍处于无收入状态，专注于 EP-104GI 和 EP-104IAR 等创新治疗的临床试验。尽管处于亏损状态，该公司报告 2024 年的净亏损减少至 2550 万美元，较去年有所改善。Eupraxia 无债务，短期资产显著超过负债，现金流可持续超过一年。最近的高管变动包括任命 Alex Rothwell 为首席财务官，考虑到他在资本市场的丰富经验，可能会增强财务战略。管理团队的平均任期为 2.4 年，表明在持续开发努力中具有适度的经验水平。</p>
<ul>
<li>点击这里阅读我们的资产负债表健康报告，深入了解 Eupraxia Pharmaceuticals 的表现。</li>
<li>通过我们的详细增长报告评估 Eupraxia Pharmaceuticals 未来的收益预期。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41b98a10-956b-4e43-8e6b-7e5eb5a9c99c/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41b98a10-956b-4e43-8e6b-7e5eb5a9c99c/chart/financial-position-analysis"/></p>
<p>截至 2025 年 4 月的 TSX:EPRX 财务状况分析</p>
<h2>Amex Exploration (TSXV:AMX)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Amex Exploration Inc.及其子公司专注于在加拿大探索黄金矿产，市值为 CA$1.0882 亿。</p>
<p><strong>运营：</strong> Amex Exploration Inc.未报告任何具体的收入细分，主要专注于在加拿大的黄金矿产探索。</p>
<p><strong>市值：</strong> CA$1.0882 亿</p>
<p>Amex Exploration Inc.的市值为 CA$1.0882 亿，处于无收入状态，专注于黄金探索。该公司最近实现了盈利，尽管其股本回报率仍然较低，为 1.1%。Amex 的战略扩张包括收购 Perron West 项目，显著增加了其在魁北克和安大略省的土地持有和探索潜力。最近来自 Perron 项目的钻探结果显示出中央多金属区的矿化延伸前景。尽管短期资产超过负债，但长期负债未能完全由当前资产覆盖。Amex 无债务，管理团队经验丰富，继续追求积极的探索战略，以增强资源潜力。</p>
<ul>
<li>点击这里深入了解 Amex Exploration 的具体情况，查看我们的资产负债表健康报告。</li>
<li>通过访问我们的收益增长报告评估 Amex Exploration 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf193b4c-6b63-4bf7-a329-87e698dec26a/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf193b4c-6b63-4bf7-a329-87e698dec26a/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 4 月的 TSXV:AMX 债务与股本历史及分析</p>
<h2>抓住机会</h2>
<ul>
<li>点击此链接访问 930 只 TSX 便士股票的完整列表。</li>
<li>寻找替代机会？我们发现 25 只预计明年将支付超过 6% 股息收益率的美国股票。免费查看完整列表。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>如果您想交易 Eupraxia Pharmaceuticals，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
<p>赞助内容</p>

EPRX

<p>多伦多证券交易所（TSX）上涨超过 2%，促使投资者探索低价股以寻找增长机会。值得注意的公司包括 Calfrac Well Services，该公司在 2024 年第四季度报告了净亏损，但预计利润将适度增长。Eupraxia Pharmaceuticals 仍处于无收入状态，但没有债务，现金流状况良好。Amex Exploration 专注于黄金开采，尽管股本回报率较低，但最近实现了盈利。这些公司突显了在更广泛市场不确定性中，鲜为人知的股票所蕴含的潜力</p>

<p>The Canadian market has shown resilience, with the TSX rising over 2% recently, even as global markets grapple with tariff uncertainties and economic pressures. In such a climate, investors often look beyond the larger indices to find opportunities in lesser-known areas like penny stocks. Although the term &#34;penny stocks&#34; might seem outdated, these smaller or newer companies can offer significant potential for growth when backed by strong financials and sound fundamentals.</p>
<div class="lb-trans"><p>加拿大市场表现出韧性，最近多伦多证券交易所（TSX）上涨超过 2%，尽管全球市场面临关税不确定性和经济压力。在这样的环境下，投资者往往会超越大型指数，寻找在小型股票等较不知名领域的机会。尽管 “便士股票” 这个术语可能显得过时，但这些较小或较新的公司在强大的财务支持和稳健的基本面下，仍然可以提供显著的增长潜力。</p>
</div><h3>Top 10 Penny Stocks In Canada</h3>
<div class="lb-trans"><h3>加拿大十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Westbridge Renewable Energy (TSXV:WEB)</td>
<td>CA$0.61</td>
<td>CA$61.7M</td>
<td>✅ 4 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>NTG Clarity Networks (TSXV:NCI)</td>
<td>CA$1.69</td>
<td>CA$69.98M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Orezone Gold (TSX:ORE)</td>
<td>CA$1.31</td>
<td>CA$685.19M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Dynacor Group (TSX:DNG)</td>
<td>CA$4.70</td>
<td>CA$198.39M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Amerigo Resources (TSX:ARG)</td>
<td>CA$1.69</td>
<td>CA$282.4M</td>
<td>✅ 2 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>PetroTal (TSX:TAL)</td>
<td>CA$0.57</td>
<td>CA$521.69M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>McCoy Global (TSX:MCB)</td>
<td>CA$2.66</td>
<td>CA$70.94M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Findev (TSXV:FDI)</td>
<td>CA$0.48</td>
<td>CA$13.18M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>BluMetric Environmental (TSXV:BLM)</td>
<td>CA$1.21</td>
<td>CA$43.57M</td>
<td>✅ 2 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>Enterprise Group (TSX:E)</td>
<td>CA$1.26</td>
<td>CA$98.46M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Westbridge Renewable Energy (TSXV:WEB)</td>
<td>CA$0.61</td>
<td>CA$6170 万</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>NTG Clarity Networks (TSXV:NCI)</td>
<td>CA$1.69</td>
<td>CA$6998 万</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Orezone Gold (TSX:ORE)</td>
<td>CA$1.31</td>
<td>CA$68519 万</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Dynacor Group (TSX:DNG)</td>
<td>CA$4.70</td>
<td>CA$19839 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Amerigo Resources (TSX:ARG)</td>
<td>CA$1.69</td>
<td>CA$2.824 亿</td>
<td>✅ 2 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>PetroTal (TSX:TAL)</td>
<td>CA$0.57</td>
<td>CA$5.2169 亿</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>McCoy Global (TSX:MCB)</td>
<td>CA$2.66</td>
<td>CA$7094 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Findev (TSXV:FDI)</td>
<td>CA$0.48</td>
<td>CA$1318 万</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>BluMetric Environmental (TSXV:BLM)</td>
<td>CA$1.21</td>
<td>CA$4357 万</td>
<td>✅ 2 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Enterprise Group (TSX:E)</td>
<td>CA$1.26</td>
<td>CA$9846 万</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 930 stocks from our TSX Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们 TSX 便士股票筛选器的 930 只股票的完整列表。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>下面我们展示了一些经过筛选的股票。</p>
</div><h2>Calfrac Well Services (TSX:CFW)</h2>
<div class="lb-trans"><h2>Calfrac Well Services (TSX:CFW)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Calfrac Well Services Ltd., along with its subsidiaries, offers specialized oilfield services in Canada, the United States, and Argentina, and has a market cap of CA$292.88 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Calfrac Well Services Ltd.及其子公司在加拿大、美国和阿根廷提供专业的油田服务，市值为 CA$2.9288 亿。</p>
</div><p><strong>Operations:</strong> The company generates its revenue primarily from oil well equipment and services, amounting to CA$1.57 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过油井设备和服务产生收入，金额为 CA$15.7 亿。</p>
</div><p><strong>Market Cap:</strong> CA$292.88M</p>
<div class="lb-trans"><p><strong>市值：</strong> CA$2.9288 亿</p>
</div><p>Calfrac Well Services, with a market cap of CA$292.88 million, recently reported a net loss for Q4 2024 amid declining sales. The company has seen significant debt reduction over the past five years, yet its current net debt to equity ratio remains high at 42.4%. While short-term and long-term liabilities are covered by assets, interest payments are not well covered by earnings. Recent executive changes could impact future strategy and operations. Despite negative earnings growth last year, Calfrac is forecasted to grow profits modestly at 4.61% annually moving forward in the competitive energy services sector.</p>
<div class="lb-trans"><p>Calfrac Well Services 的市值为 CA$2.9288 亿，最近报告了 2024 年第四季度的净亏损，销售额下降。过去五年，该公司的债务显著减少，但其当前的净债务与股本比率仍高达 42.4%。虽然短期和长期负债由资产覆盖，但利息支付未能得到盈利的良好覆盖。最近的高管变动可能会影响未来的战略和运营。尽管去年盈利增长为负，Calfrac 预计在竞争激烈的能源服务行业中，未来的利润将适度增长 4.61%。</p>
</div><ul>
<li>Click here to discover the nuances of Calfrac Well Services with our detailed analytical financial health report.</li>
<li>Review our growth performance report to gain insights into Calfrac Well Services' future.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里了解 Calfrac Well Services 的细微差别，查看我们的详细财务健康报告。</li>
<li>查看我们的增长表现报告，以获取对 Calfrac Well Services 未来的洞察。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/e9eb34c4-7b23-4bc4-a84f-cbb170d0732b/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/e9eb34c4-7b23-4bc4-a84f-cbb170d0732b/chart/revenue-and-expenses-breakdown"/></p>
<p>TSX:CFW Revenue &amp; Expenses Breakdown as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 TSX:CFW 收入与支出细分</p>
</div><h2>Eupraxia Pharmaceuticals (TSX:EPRX)</h2>
<div class="lb-trans"><h2>Eupraxia Pharmaceuticals (TSX:EPRX)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Eupraxia Pharmaceuticals Inc. is a clinical stage biotechnology company focused on discovering, developing, and marketing technologies in the biotechnology sector, with a market cap of CA$159.17 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Eupraxia Pharmaceuticals Inc.是一家临床阶段的生物技术公司，专注于发现、开发和营销生物技术领域的技术，市值为 CA$1.5917 亿。</p>
</div><p><strong>Operations:</strong> Eupraxia Pharmaceuticals Inc. has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>运营：</strong> Eupraxia Pharmaceuticals Inc.尚未报告任何具体的收入细分。</p>
</div><p><strong>Market Cap:</strong> CA$159.17M</p>
<div class="lb-trans"><p><strong>市值：</strong> CA$1.5917 亿</p>
</div><p>Eupraxia Pharmaceuticals Inc., with a market cap of CA$159.17 million, remains pre-revenue as it focuses on clinical trials for innovative treatments like EP-104GI and EP-104IAR. Despite its unprofitable status, the company reported a reduced net loss of US$25.5 million for 2024 compared to the previous year. Eupraxia is debt-free, with short-term assets significantly exceeding liabilities and a cash runway extending over a year. Recent executive changes include appointing Alex Rothwell as CFO, potentially enhancing financial strategy given his extensive capital markets experience. The management team has an average tenure of 2.4 years, indicating moderate experience levels amidst ongoing development efforts.</p>
<div class="lb-trans"><p>Eupraxia Pharmaceuticals Inc.的市值为 CA$1.5917 亿，仍处于无收入状态，专注于 EP-104GI 和 EP-104IAR 等创新治疗的临床试验。尽管处于亏损状态，该公司报告 2024 年的净亏损减少至 2550 万美元，较去年有所改善。Eupraxia 无债务，短期资产显著超过负债，现金流可持续超过一年。最近的高管变动包括任命 Alex Rothwell 为首席财务官，考虑到他在资本市场的丰富经验，可能会增强财务战略。管理团队的平均任期为 2.4 年，表明在持续开发努力中具有适度的经验水平。</p>
</div><ul>
<li>Get an in-depth perspective on Eupraxia Pharmaceuticals' performance by reading our balance sheet health report here.</li>
<li>Assess Eupraxia Pharmaceuticals' future earnings estimates with our detailed growth reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里阅读我们的资产负债表健康报告，深入了解 Eupraxia Pharmaceuticals 的表现。</li>
<li>通过我们的详细增长报告评估 Eupraxia Pharmaceuticals 未来的收益预期。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41b98a10-956b-4e43-8e6b-7e5eb5a9c99c/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/41b98a10-956b-4e43-8e6b-7e5eb5a9c99c/chart/financial-position-analysis"/></p>
<p>TSX:EPRX Financial Position Analysis as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 TSX:EPRX 财务状况分析</p>
</div><h2>Amex Exploration (TSXV:AMX)</h2>
<div class="lb-trans"><h2>Amex Exploration (TSXV:AMX)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Amex Exploration Inc., along with its subsidiaries, focuses on exploring gold mining properties in Canada and has a market capitalization of CA$108.82 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Amex Exploration Inc.及其子公司专注于在加拿大探索黄金矿产，市值为 CA$1.0882 亿。</p>
</div><p><strong>Operations:</strong> Amex Exploration Inc. does not report any specific revenue segments, as it is primarily focused on the exploration of gold mining properties in Canada.</p>
<div class="lb-trans"><p><strong>运营：</strong> Amex Exploration Inc.未报告任何具体的收入细分，主要专注于在加拿大的黄金矿产探索。</p>
</div><p><strong>Market Cap:</strong> CA$108.82M</p>
<div class="lb-trans"><p><strong>市值：</strong> CA$1.0882 亿</p>
</div><p>Amex Exploration Inc., with a market cap of CA$108.82 million, is pre-revenue, focusing on gold exploration. The company has achieved profitability recently, though its Return on Equity remains low at 1.1%. Amex's strategic expansion includes acquiring the Perron West Project, significantly increasing its land holdings and exploration potential in Quebec and Ontario. Recent drill results from the Perron Project indicate promising mineralization extensions in the Central Polymetallic Zone. Despite short-term assets exceeding liabilities, long-term liabilities are not fully covered by current assets. With no debt and a seasoned management team, Amex continues to pursue aggressive exploration strategies to enhance resource potential.</p>
<div class="lb-trans"><p>Amex Exploration Inc.的市值为 CA$1.0882 亿，处于无收入状态，专注于黄金探索。该公司最近实现了盈利，尽管其股本回报率仍然较低，为 1.1%。Amex 的战略扩张包括收购 Perron West 项目，显著增加了其在魁北克和安大略省的土地持有和探索潜力。最近来自 Perron 项目的钻探结果显示出中央多金属区的矿化延伸前景。尽管短期资产超过负债，但长期负债未能完全由当前资产覆盖。Amex 无债务，管理团队经验丰富，继续追求积极的探索战略，以增强资源潜力。</p>
</div><ul>
<li>Dive into the specifics of Amex Exploration here with our thorough balance sheet health report.</li>
<li>Evaluate Amex Exploration's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里深入了解 Amex Exploration 的具体情况，查看我们的资产负债表健康报告。</li>
<li>通过访问我们的收益增长报告评估 Amex Exploration 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/cf193b4c-6b63-4bf7-a329-87e698dec26a/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/cf193b4c-6b63-4bf7-a329-87e698dec26a/chart/debt-equity-history-analysis"/></p>
<p>TSXV:AMX Debt to Equity History and Analysis as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 TSXV:AMX 债务与股本历史及分析</p>
</div><h2>Seize The Opportunity</h2>
<div class="lb-trans"><h2>抓住机会</h2>
</div><ul>
<li>Access the full spectrum of 930 TSX Penny Stocks by clicking on this link.</li>
<li>Looking For Alternative Opportunities? We've found 25 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此链接访问 930 只 TSX 便士股票的完整列表。</li>
<li>寻找替代机会？我们发现 25 只预计明年将支付超过 6% 股息收益率的美国股票。免费查看完整列表。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>If you're looking to trade Eupraxia Pharmaceuticals, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 Eupraxia Pharmaceuticals，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

TSX 便士股亮点：Calfrac Well Services 及另外两个引人注目的选择